Amorfix Life Sciences is a theranostics company developing therapeutic products and diagnostic devices targeting misfolded protein diseases including ALS, cancer and Alzheimer’s disease. AMF currently offers four types of products: therapeutics, diagnostic kits, diagnostic services and reagents. The company’s scientists … Continue reading →

Sernova is a clinical stage health-sciences company focused on commercializing medical technologies. The company is currently developing a platform technology for a number of serious disease indications, starting with a novel treatment for insulin-dependent diabetes, using the novel Cell Pouch … Continue reading →

Allon Therapeutics is a clinical-stage biotechnology company focused on innovative central nervous system therapies. NPC’s lead drug davunetide is currently in a fully enrolled pivotal phase 2/3 clinical trial in an orphan indication, progressive supranuclear palsy (PSP), under a Special … Continue reading →

iBio develops and offers product applications of its iBioLaunch™ platform, which provides collaborators full support for turn-key implementation of the company’s technology for both proprietary and biosimilar products. IBIO’s iBioLaunch platform is a proprietary, transformative technology for the development and … Continue reading →

Cellceutix is an emerging biopharmaceutical company focused on the development of its pipeline of compounds targeting areas of unmet medical need. CTIX’ flagship compound is Kevetrin™, an anti-cancer drug. The company also owns the rights to seven other drug compounds, … Continue reading →

MRI Interventions creates innovative platforms for performing minimally invasive surgical procedures in the brain and heart. By utilizing a hospital’s existing MRI suite, MRIC’s FDA-cleared ClearPoint® system is designed to enable a range of minimally invasive procedures in the brain. … Continue reading →

AtheroNova operates through its wholly owned subsidiary, AtheroNova Operations Inc., as an early stage biotech company focused on the discovery, research, development and licensing of novel compounds to reduce or regress atherosclerotic plaque deposits. AHRO has developed intellectual property for … Continue reading →

Echo Therapeutics is a transdermal medical device company specializing in advanced skin permeation technology. ECTE is developing its Prelude® SkinPrep System as a platform technology to allow for significantly enhanced and painless skin permeation that will enable: needle-free drug delivery, … Continue reading →

Gasco Energy is an independent oil and gas company engaged in the development of large natural gas deposits in the U.S. Rocky Mountain region and on exploratory oil plays in the San Joaquin Basin in California. With a focus primarily … Continue reading →

Immunovaccine is a clinical stage vaccine development company focused on advancing its patented DepoVax™ vaccine adjuvanting platform and product candidates for cancer therapy and infectious diseases. The company’s pre-clinical stage vaccine product candidates comprise pandemic influenza and Hepatitis B vaccine … Continue reading →